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Cerebral malaria (CM) is the most severe complication associated with Plasmodium
falciparum infection. The exact pathogenic mechanisms leading to the development
of CM remains poorly understood while the mortality rates remain high. Several
potential mechanisms including mechanical obstruction of brain microvasculature,
inflammation, oxidative stress, cerebral energy defects, and hemostatic dysfunction
have been suggested to play a role in CM pathogenesis. However, these proposed
mechanisms, even when considered together, do not fully explain the pathogenesis
and clinicopathological features of human CM. This necessitates consideration of
alternative pathogenic mechanisms. P. falciparum generates substantial amounts of
ammonia as a catabolic by-product, but lacks detoxification mechanisms. Whether this
parasite-derived ammonia plays a pathogenic role in CM is presently unknown, despite its
potential to cause localized brain ammonia elevation and subsequent neurotoxic effects.
This article therefore, explores and proposes a potential role of parasite-derived ammonia
in the pathogenesis and neuropathology of CM. A consideration of parasite-derived
ammonia as a factor in CM pathogenesis provides plausible explanations of the various
features observed in CM patients including how a largely intravascular parasite can cause
neuronal dysfunction. It also provides a framework for rational development and testing
of novel drugs targeting the parasite’s ammonia handling.
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Introduction
Cerebral malaria (CM) is one of the most common and fatal complications associated with
Plasmodium falciparum infection (Newton et al., 2000). Despite the availability of effective anti-
malarial drugs, CM mortality rates in malaria aﬄicted regions remain high, ranging between 15
and 20% (Mishra and Newton, 2009). This has partly been attributed to the fact that a number of
patients succumb to CM before the onset of administered anti-malarial therapeutic effects (Mishra
and Newton, 2009). Transient and persistent neurocognitive impairments are also common
among cerebral malaria survivors, mostly children (van der Wal et al., 2005; Idro et al., 2010).
Several mechanisms have been hypothesized to play a role in the pathogenesis of CM including;
mechanical obstruction of brain microvasculature by sequestered parasitized red blood cells
(PRBCs), inflammation, hemostatic dysfunction, excessive parasite-derived lactate, and oxidative
stress (Berendt et al., 1994; Medana et al., 2001; van der Heyde et al., 2006; Mariga et al., 2014).
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However, the exact pathogenesis of CM remains poorly
understood and the various clinicopathological features of
human CM cannot be fully explained by the existing hypotheses
(van der Heyde et al., 2006). Additionally, adjunctive therapies
targeting some of these earlier proposed pathogenic mechanisms
have failed to improve CM treatment outcomes or have been
found detrimental in human clinical studies (White et al., 2013).
Exploration of other potential pathogenic factors is therefore
needed in order to understand the underlying CM pathogenesis
and develop adjunctive therapies that can possibly prolong anti-
malarial therapeutic window and reduce neurocognitive sequelae
among survivors.
Ammonia is a neurotoxic metabolic by-product whose blood
concentration is tightly maintained at levels of less than
50µmol/L mainly by the action of liver glutamine synthetase,
which has a lower Km for ammonia than carbamoyl-phosphate
synthetase (Arn et al., 1990; Cohn and Roth, 2004; Adeva et al.,
2012). The brain astrocytic glutamine synthetase also plays a
minor role, converting upto 25% of blood derived ammonia
to glutamine (Eid and Lee, 2013). Several factors including,
acute liver failure (ALF), urea cycle disorders, Reye’s syndrome
and hepatic drug toxity may however interfere with the normal
ammonia metabolism leading to hyperammonemia (Cohn and
Roth, 2004). Regardless of the cause, elevations of blood
ammonia concentration above the normal physiological levels
often lead to encephalopathies (Haberle, 2013). Interestingly,
the clinicopathological features of acquired and congenital
hyperammonemic encephalopathies such as coma, brain edema,
and seizures (Summar et al., 2008; Haberle, 2013) are analogous
to some of the features observed in CMpatients (Idro et al., 2005).
Moreover, experimental cerebral malaria (ECM) in murine
models has also revealed metabolic changes that point toward
parasite-induced perturbation of ammonia detoxification (Ghosh
et al., 2012). These observations, coupled to the fact that
P. falciparum generates large amounts of ammonia in the
absence of intrinsic parasite detoxification mechanisms (Zeuthen
et al., 2006) clearly suggests a potential role of parasite-derived
ammonia in CM pathogenesis.
It was recently hypothesized that development of ALF in
malaria patients may lead to accumulation of ammonia and
other neurotoxins, which then enter the brain aided by blood
brain barrier (BBB) breakdown and ultimately cause neurological
damage and manifestation of CM (Martins and Daniel-Ribeiro,
2013). However, several studies indicates that parasite-induced
liver dysfunction is not a common occurrence in P. falciparum
malaria (Anand et al., 1992; Murthy et al., 1998; Nacher
et al., 2001; Mazumder et al., 2002; Mohanty et al., 2004;
Prommano et al., 2005; Kochar et al., 2010; Whitten et al., 2011).
Therefore, it is conceivable that sequestered parasites in the
brain vasculature known to produce large amounts of ammonia
as a catabolic by-product, may disrupt normal brain ammonia
metabolism leading to local accumulation of ammonia. This
possibility has however not been considered as a pathogenic
factor in CM. The aim of the current article is therefore to
explore potential mechanisms by which P. falciparum may
cause localized elevation of brain ammonia and subsequent
neurotoxicity.
Human Brain Ammonia Uptake and
Metabolism
The human brain usually takes up ammonia from cerebral
blood vessels using different transport mechanisms. The non-
protonated NH3 form is easily taken up by simple diffusion
and there is usually a positive linear correlation between
arterial ammonia concentration and brain uptake (Cooper
and Plum, 1987). The ammonium ion NH+4 on the other
hand does not easily cross the BBB but is transported by
carrier-mediated processes that utilize an array of potassium
channels and transporters or by substituting other cations
with similar hydrated radius (Ott and Larsen, 2004). Once
in the astrocytes, ammonia combines with glutamate in an
ATP-dependent reaction, catalyzed by glutamine synthetase (l-
glutamate:ammonia ligase (ADP-forming; E.C.6.3.1.2) (GS) to
form glutamine, which is then released into the blood stream
(Cooper and Plum, 1987; Adeva et al., 2012) (Figure 1). Since
the brain lacks effective urea cycle, this astrocyte GS catalyzed
conversion of ammonia to glutamine and release into the
blood stream is almost the only means to limit brain ammonia
concentration (Cooper and Plum, 1987; Adeva et al., 2012). The
astrocyte GS reaction also plays a role during acute systemic
hyperammonemic conditions, where excess blood ammonia
(NH3/ NH
+
4 ) is avidly taken up by the astrocytes and converted to
glutamine, leading to increased brain and blood glutamine levels
(Olde Damink et al., 2002; Brusilow et al., 2010).
Moreover, the astrocytic GS reaction is involved in glutamine-
glutamate (GABA) cycle, which serves an important role in
glutamatergic and GABAergic neurotransmission. In this cycle
glutamate released from the glutamatergic neurons is taken up
by the astrocytes and converted by GS reaction to glutamine,
which is then transported back to neurons and converted to
glutamate by neuronal phosphate-activated glutaminase with a
concomitant release of ammonia (Zwingmann and Butterworth,
2005; Hertz, 2013).
Can P. falciparum Cause Local Elevation
of Brain Ammonia Levels?
The blood stage of P. falciparum degrades host hemoglobin
to obtain free amino acids and imports some amino acids,
particularly glutamine from the host serum (Elford et al.,
1985; Goldberg, 2005). Although the parasite utilizes most of
these free amino acids for protein biosynthesis, glutamine is
usually deamidated and further deaminated and oxidized to 2-
oxogluterate in order to maintain parasite’s cellular levels of
reduced NADPH + H+ (Werner et al., 2005). This deamidation
and subsequent deamination reactions generates two molecules
of ammonia per glutamine molecule. Thus, the malaria parasites
require large amounts of glutamine and can produce substantial
amounts of ammonia during the developmental life stages that
require NADPH + H+. Indeed, an ammonia production rate of
0.8 fmol/h per parasite or 9mmol/h per litre of packed infected
erythrocytes has been demonstrated in the early trophozoite
stage of P. falciparum (Zeuthen et al., 2006). Production
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FIGURE 1 | Potential ammonia-glutamine vicious cycle in which
intravascular malaria parasites catabolize glutamine, releasing
ammonia, which is taken up into the astrocyte via
transporters including NCCK1 and conjugated with glutamate
(derived from α-ketoglutarate) to form glutamine in a
glutamine synthetase (GS) catalyzed reaction. The generated
glutamine may then be released back to blood thus resupplying
the parasite with the necessary glutamine. The GS catalyzed
reaction also plays a key role in the glutamine-glutamate cycle, in
which released synaptic glutamate is recycled back to the
glutamatergic neurons in form of glutamine and converted by
glutaminase to form glutamate neurotransmitter.
of such amounts of ammonia may present a huge toxicity
challenge to a parasite that lack ammonia-detoxifying machinery.
However, studies suggest that the parasite may circumvent the
toxic effects of ammonia by exporting it to the erythrocyte
cytoplasm via P. falciparum aquaglyceroporin (PfAQP) and
eventually into the extra-erythrocytic fluid (Zeuthen et al., 2006).
Therefore, sequestration of a large number of metabolically active
trophozoites and schizonts in a particular tissue vasculature may
lead to release of massive amounts of ammonia into the blood
stream.
In the human host, sequestration of PRBCs occur mainly
in the brain microvasculature, with up to 10–20% of the total
parasite biomass being estimated to be sequestered in the brain of
some fatal CM cases (White et al., 2013). The sequestered PRBCs
usually contain the mature trophozoite and schizonts (Silamut
et al., 1999), which as already noted, takes up large amounts of
glutamine from the extracellular fluid with concomitant increase
in ammonia production (Elford et al., 1985; Zeuthen et al., 2006).
The release of this parasite-derived ammonia in the human
host most likely increases brain ammonia uptake, owing to
reduced blood flow in congested microvessels and the fact that
the brain ammonia uptake usually increases proportionally to
the prevailing blood ammonia levels (Cooper and Plum, 1987).
Subsequent detoxification of the increased brain ammonia via
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astrocytic GS reaction would in turn generate glutamine, which
would then be released into the blood stream, as is the case
during acute hyperammonemic conditions (Olde Damink et al.,
2002). Interestingly, this would set up a vicious cycle whereby
the sequestered parasites get rid of its toxic ammonia and
at the same time sustains a continuous supply of glutamine
by exploiting the host’s astrocytic ammonia metabolic pathway
(Figure 1). Such a cycle would enhance survival and rapid
expansion of metabolically active sequestered parasite mass in
the brain, thus sustaining and escalating ammonia production.
Indeed malaria parasites are known to exploit or dysregulate
other host’s metabolic pathways to favor their survival and
proliferation (Olszewski et al., 2009). However, the brain
ammonia detoxification pathway capacity is limited andmight be
saturated by a sustained high rate of parasite-derived ammonia,
thus leading to its accumulation and neurotoxicty. Moreover, but
to a minor extent, an increased astrocytic glutamine output may
also lead to increased glutamine uptake and subsequent release
of ammonia by glutaminase-catalyzed reaction in the neurons.
Therefore, P. falciparum particularly the sequestered parasites in
the brain can create foci of increased ammonia production that
may directly elevate brain ammonia, without the involvement of
liver dysfunction.
Secondarily, other factors associated with P. falciparum
infection may further contribute toward elevation of brain
ammonia levels. Sequestered PRBCs, rosettes and reduced
RBC deformability for example, may transiently reduce local
microvascular perfusion leading to local tissue hypoxia. In such
tissue regions, ammonia accumulation may be accelerated due to
hypoxia-driven increase in amino acid catabolism (Cooper and
Plum, 1987). Sequestered PRBCs in the brain may also create foci
of enhanced immune cells activation and inflammatory responses
(Porta et al., 1993; Patnaik et al., 1994; Medana et al., 2001).
Activation of immune cells has been associated with increased
uptake and utilization of glutamine to meet high energy demands
required for effective immune functions (Curi et al., 1999).
Glutamine catabolism by the activated immune cells may thus
lead to enhanced ammonia production in the affected brain areas.
Moreover, elevated reactive oxygen species (ROS) levels during
their respiratory burst may compromise astrocytic ammonia
detoxification events via inhibition of the the ROS sensitive GS
(Brand et al., 1999), further aggravating the ammonia burden in
the affected brain regions.
Hypoglycemia known to occur in up to one third of CM
patients on admission (Idro et al., 2005) results in impaired
energy metabolism and may also reduce ATP production. This
would in turn exacerbate GS inhibition as a consequence of
its reliance on ATP for enzymatic activity further contributing
to ammonia accumulation. Fever and seizures, have also been
shown to increase the rate of ammonia production in the
vertebrate body (Cooper and Plum, 1987). Therefore, malaria
induced fever and initial seizure episodes (mainly febrile) can
contribute to heightened production of ammonia in the brain.
It is also possible that an initial slight to moderate increase in
brain ammonia concentration by parasite’s glutamine catabolic
processes impairs the Krebs cycle, probably via inhibition of key
metabolic enzymes like α-ketoglutarate (αKG) dehydrogenase
(Cooper and Plum, 1987) and electron transport chain enzymes
(Qureshi et al., 1998). Furthermore, the carbon needed to
detoxify the excess parasite-derived ammonia depletes α-KG
from cells, thereby additionally affecting the Krebs cycle (Ott
et al., 2005). Pathophysiological concentrations of ammonia have
also been shown to increase ROS production with resultant
induction of mitochondrial permeability transition (MPT) in
the astrocyte (Rama Rao et al., 2005). All these may ultimately
reduce astrocyte ATP production thus setting up a vicious cycle
in which ammonia impairs its own detoxification, leading to
marked accumulation of ammonia and a further impairment of
energy metabolism. Similarly, an initial parasite driven increase
of ammonia can also decrease astrocyte expression of glutamate
transporters (Chan et al., 2000) or increase ROS production
(Rama Rao et al., 2005), further impairing ammonia brain
metabolism.
In summary therefore, presence of a large number of
metabolically active parasites in the brain can directly generate
substantial amount of ammonia, as a metabolic byproduct, which
may in turn overwhelm brain ammonia metabolism, leading
to localized elevation of brain ammonia. The sequestration of
PRBCs in the brain microvasculature is most likely the key factor
that creates the large pool of parasites necessary to overwhelm the
brain’s ammonia detoxification capacity.
Elevated Brain Ammonia Hypothesis
In the human body ammonia exist at equilibrium as NH3(a weak
base) and NH+4 (weak acid), with the latter having electrolytic
conductance and ionic properties very similar to those of K+
ion (Bosoi and Rose, 2009). NH3 readily permeates membrane
while the protonated NH+4 form crosses membranes via channels
and substitution of K+ ion at its transporters (Nagaraja and
Brookes, 1998). Elevated levels of ammonia alters brain function
via direct as well as indirect mechanisms and has been considered
to be a key factor in the pathogenesis of various metabolic
encephalopathies (Butterworth et al., 1987; Butterworth, 1998;
Bosoi and Rose, 2009; Haberle, 2013). We hypothesize that acute
localized elevation of brain ammonia primarily by sequestered
malaria parasites initiates a cascade of toxic effects that ultimately
lead to the various CM clinical manifestations including brain
edema, seizures, coma and neurological sequlae (Figure 2).
Brain edema and the associated raised intracranial pressure
(ICP) and intracranial hypertension commonly observed in
CM (Idro et al., 2005; Medana et al., 2011) may occur
primarily due to ammonia-induced astrocyte swelling. This is
because acute elevation of brain ammonia by the parasite and
subsequent uptake into the brain would stimulate astrocytic GS
catalyzed glutamine synthesis, leading to a rapid accumulation
of glutamine. Intracellular accumulation of glutamine is
known to cause astrocyte swelling via various mechanisms
including increased osmotic stress (Norenberg et al., 1991;
Butterworth, 1998), or enhanced oxidative/nitrative stress
(ONS) and induction of MPT following uptake into the
mitochondria (Albrecht and Norenberg, 2006). The physico-
chemical similarities between NH+4 and K
+ may also play a role
in excess ammonia mediated atrocyte swelling as suggested by
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FIGURE 2 | Potential mechanisms by which cerebral malaria
manifestations can develop. Massive sequestration of parasites in brain
microvasculature increases brain ammonia levels and thereby causing
ammonia toxicity (middle and left columns). Some additional effects of the
malaria infection including inflammation and disrupted BBB further
enhance this toxicity (right column). The cause of death may be
multifactorial including deep coma, edema and prolonged repetitive
seizures.
studies showing that ammonia activates Na-K-Cl cotransporter-
1 (NKCC1) and oubain-activated signaling pathway (Rama Rao
et al., 2005, 2014a; Jayakumar et al., 2011; Song and Du, 2014).
Moreover, excess ammonia increases the levels of aquaporin 4
water channel (AQP4) in the brain (Pan et al., 2010; Bodega
et al., 2012), which may play a role in astrocyte swelling and brain
edema (Eefsen et al., 2010; Rama Rao et al., 2010b, 2014b). While
these mechanisms are yet to be investigated in the pathogenesis
of CM edema, a few recent studies points toward a potential
role. Brain autopsy studies of CM patients with cereberal edema,
for example found a trend toward increased AQP4 channels in
the brain stem (Medana et al., 2011). Increased brain and blood
glutamine levels have also been reported in ECM (Ghosh et al.,
2012), lending support to our postulated ammonia-mediated
genesis of cytotoxic edema in CM.
The brain endothelial cells also expresses NKCC1, whose
activation increases Na+ and Cl− transport into brain and
has been implicated in the genesis of edema in stroke and
experimental ischemic models (O’Donnell et al., 2004). Recent
studies also indicate that ammonia activates the nuclear factor
kappa B (NF-κB) pathway in brain endothelial cells, thereby
contributing to astrocyte swelling and edema in ALF (Jayakumar
et al., 2012, 2014). Therefore, it is possible that the widespread
activation of brain endothelial cells (Combes et al., 2004; Idro
et al., 2010) and up-regulation of NF-κB pathway by PRBCs
(Tripathi et al., 2006, 2009) may partly be driven by the parasite-
derived ammonia. The endothelial cell activation coupled with
ammonia-mediated stimulation of BBB endothelial cell NKCC1
co-transporter activity, may in turn further contribute to the
development and progression of brain swelling during CM.
Seizures and altered consciousness including deep coma
are also commonly observed among CM patients, particularly
children (Molyneux et al., 1989; Idro et al., 2010). We postulate
that these manifestations are due to unique chemical properties
of ammonia and its effects on key excitatory and inhibitory
neurotransmitter systems at pathophysiological levels. A rapid
increase in ammonia would not only result in intracellular
alkalinization (increased intracellular pH) of astrocytes but also
impairs extracellular K+ buffering capacity of the astrocytes
(Marcaggi and Coles, 2001; Bosoi and Rose, 2009; Rangroo
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Thrane et al., 2013). The consequent rise in extracellular [K+]
and overactivation of the Na+-K+-2Cl−cotransporter isoform 1
(NKCC1) in neurons in turn leads to selective impairment of
cortical inhibitory GABAergic networks, neuronal disinhibition
and seizures if ammonia concentration becomes very high
(Rangroo Thrane et al., 2013).
Moreover, excess ammonia enhances excitatory glutamatergic
neurotransmission via different mechanisms. Elevated ammonia
for, example reduces astrocytic glutamate uptake and increases
neuronal glutamate release, leading to elevated extracellular
glutamate levels and enhanced excitatory glutamatergic activity
(Raabe, 1987; Rose, 2002; Chan and Butterworth, 2003). Acute
exposure of astrocytes to ammonia and consequent intracellular
alkalinization also results in a calcium-dependent glutamate
release (Rose et al., 2005). Collectively, these would increase
extracellular glutamate thereby enhancing glutamatergic-
mediated excitatory neurotransmission. Enhanced glutamatergic
activity predispose the brain to seizures and excitotoxity
(Meldrum, 1994; Stafstrom and Sasaki-Adams, 2003). Recent
studies also suggest that prolonged exposure of astrocytes
to extracellular glutamate down-regulates astrocytic inward
rectifying potassium (Kir4.1) channels (Obara-Michlewska
et al., 2011, 2014), a phenomenon which has been shown to be
epileptogenic (Jansen et al., 2005).
In line with these observations, the seizures observed
in CM may thus arise due ammonia-induced neuronal
disinhibition and enhancement of glutamatergic activity. In
support of these postulated mechanisms, biochemical changes
indicative of increased glutamatergic activity have previously
been reported in a murine CM model (Rae et al., 2004). The
enhanced glutamatergic activity may however be transient since
prolonged presence of increased glutamate in the synapse may
cause downregulation of postsynaptic glutamate receptors, as
an intrinsic protective response. Both N-methyl-D-aspartate
(NMDA) and non-NMDA glutamate receptors for example are
reduced in animal models of ALF, and this has been suggested
to act as a counter mechanism against the detrimental effect
of prolonged elevated extracellular levels of glutamate (Chan
and Butterworth, 2003). Downregulation of glutamate mediated
excitatory synaptic transmission, coupled with direct and indirect
enhancement of GABAergic system by ammonia would depress
brain activity, leading to coma (Basile, 2002). Indeed, an elevation
of CNS tissue ammonia to 0.5µmol/g, has been suggested to
sufficiently disturb excitatory and inhibitory neurotransmission,
leading to initiation of acute encephalopathy (Raabe, 1987).
Notably and of particular interest is that the coma in
CM usually occurs rapidly often succeeding seizure onset and
most patients recover quickly from the coma without much
neurological impairments upon effective anti-malarial therapy
(Molyneux et al., 1989; Idro et al., 2010). These observations
fits well with our proposed patho-mechanisms and sequence
of events i.e., elevated ammonia transiently enhances excitatory
neurotransmission followed by compensatory measures that
depresses brain activity ultimately leading to coma. Similarly,
the rapid recovery from coma by most CM patients without
much neurological impairment can be plausibly explained by
our postulated mechanisms. A timely and effective anti-malarial
therapy would basically reduce the quantity of sequestered
ammonia-producing parasites, which in turn would promote
restoration of normal brain ammonia metabolism, and return to
normal neurotransmission.
Hypoglycaemia and lactic acidosis are also commonly
observed among CM patients (Idro et al., 2005). While
several factors such as reduced food intake, vomiting, hypoxia,
heavy parasitemia, and systemic organ failures may lead to
hypoglycemia and lactic acidosis, we hypothesize that ammonia-
driven alteration of brain energy metabolism may play a major
role. Ammonia disrupts the Krebs cycle via inhibition of
alpha-ketoglutarate dehydrogenase (KGDH), leading to reduced
mitochondrial production of ATP and reducing equivalents such
as nicotinamide adenine dinucleotide (NADH) (Ott et al., 2005).
Elevated ammonia also causes a metabolic shift toward glycolytic
metabolism with concomitant increase in lactate formation (Kala
and Hertz, 2005; Andersson et al., 2009). Increased lactate
concentrations inhibit astrocytic glutamate uptake capacity
(Andersson et al., 2009), which may further cripple the Krebs
cycle through diminished anaplerotic replenishment of KGDH.
The resultant reliance of the glycolytic pathway ATP production
by the astrocytes in the wake of an increased need for ATP-
dependent detoxification of excess ammonia would not only
increase lactate and reduce pyruvate/lactate ratio but will also
lead to rapid depletion of blood glucose. The lactic acidosis
observed in CM may thus be largely due to ammonia-induced
crippling of Krebs cycle and switch to the lactate producing
glycolytic pathway. The observed hypoglycemia may be partly
due to rapid depletion of glucose by the energetically inefficient
glycolytic pathway, which generates only two molecules of ATP
per glucose molecule. Such a consideration, may explain why
restoration of normoglycemia in hypoglycemic CM patients, is
not often associated with a change in the level of consciousness
(Newton et al., 2000).
Increased CSF quinolinic acid and picolinic acid has been
observed in children with CM but the exact cause is not well-
understood (Dobbie et al., 2000; Medana et al., 2003). We
hypothesize that the effects of elevated brain ammonia on
tryptophan uptake and metabolism play a key role. Generally,
free tryptophan is metabolized via the kynurenine pathway
into a series of bioactive metabolites including kynurenine,
kynurenic acid, 3-Hydroxykynurenine, 3-Hydroxyanthranilic
acid, picolinic acid, anthranilic acid, xanthurenic acid, and
quinolinic acid (Stone and Darlington, 2002; Stone et al., 2013).
Among these metabolites, quinolinic acid is an excitotoxic
N-methyl-D-aspartate (NMDA) glutamate receptor agonist,
while kynurenic acid is a neuroprotective glutamate receptor
antagonist (Stone and Perkins, 1981; Stone, 2001; Schwarcz
and Pellicciari, 2002; Guillemin, 2012). Quinolinic acid is
also a pro-oxidant, an immunomodulator and promotes the
formation of hyperphosphorylated tau proteins in the nervous
system (Guillemin et al., 2003; Rahman et al., 2009). Notably,
the synthesis of the neuroprotectant kynurenic acid in the
brain occur mainly within the astrocytes, while the synthesis
of 3-hydroxykynurenine and further downstream metabolites
including quinolinic acid occur in microglia (Stone et al., 2013).
Excess ammonia is known to increase brain tryptophan uptake
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even in absence of any liver function derangement (Bachmann
and Colombo, 1983). It also inhibits kynurenic acid synthesis
from kynurenine in a dose-dependent manner (Saran et al.,
1998) and increases cerebral blood flow (Aggarwal et al., 1994;
Jalan et al., 2004b). By increasing cerebral blood flow as CM
progresses, elevated ammonia may thus increase tryptophan
uptake from the blood. However, subsequent metabolism will
be skewed in favor of increased level of microglia-derived
quinolinic acid and less of neuroprotectant kynurenic acid since
elevated ammonia also reduces kynurenic acid synthesis (Saran
et al., 1998). The increased quinolinic acid would in turn
contribute to altered NMDA receptor activity and excitotoxity
(Stone and Perkins, 1981; Guillemin, 2012) as well as increased
CNS proinflammatory cytokine production and oxidative stress
(Guillemin et al., 2003).
Systemic inflammatory response is common during P.
falciparum malaria infections, leading to increased blood
concentration of both pro-inflammatory and anti-inflammatory
cytokines. Among some patients who develop CM, various
blood pro-inflammatory cytokines have been reported to increase
including interleukin 1 beta (IL-1β), IL-6, and tumor necrosis
factor alpha (TNF-α) (Kwiatkowski et al., 1990; Ringwald et al.,
1991; Brown et al., 1999; Wenisch et al., 1999; Akanmori et al.,
2000; Lyke et al., 2004). Therefore, a key role of inflammation
in CM pathogenesis and pathology cannot be overlooked.
We hypothesize that parasite-elicited systemic inflammation
potentiates the proposed elevation of brain ammonia and
subsequent neurotoxicity. This may include potentiation of
brain ammonia uptake (Duchini et al., 1996) as well as the
untoward effects of excess ammonia on neurocognitive functions
(Shawcross et al., 2004; Marini and Broussard, 2006), astrocyte
osmotic balance (Oh et al., 1992; Rama Rao et al., 2010a) and
synaptic neurotransmission (Casamenti et al., 1999; Hu et al.,
2000; Medana et al., 2001). The systemic inflammation may also
synergize ammonia-induced pathogenic alteration of cerebral
blood flow (CBF) and increased ICP as previously observed both
in human and animal studies of hyperammonemia (Jalan et al.,
2004b; Pedersen et al., 2007). Moreover, inflammatory cytokines
particularly TNF-α promotes sequestration of PRBCs (Idro et al.,
2010), the primary event that leads to elevation of brain ammonia
according to our hypothesis.
Potentially also, elevated brain ammonia may elicit CNS
based inflammatory response via direct activation of microglia
and astrocytes. This is because CNS based cells particularly
astrocytes, microglia, and oligodendrocytes are known to initiate
inflammation in response to local noxious stimuli (Lucas et al.,
2006) and high concentrations of ammonia has been shown to
be a potent inflammatory stimuli. In one in vitro study, for
example, ammonia was reported to directly stimulate secretion
of TNF-α and IL-8 by immortalized humanmicroglia (CHME-5)
and astroglioma (GL-15) cells even in the absence of any other
stimulus (Atanassov et al., 1995). Such a possibility of ammonia
induced CNS inflammatory response, may explain the observed
widespread activation of microglial throughout the brain in white
and gray matter and far beyond areas of petechial bleedings or
sequestered PRBCs foci during CM (Schluesener et al., 1998).
It may also explain the induction and CNS production of the
pro-inflammatory cytokines that has been observed in children
with CM (Brown et al., 1999; John et al., 2008). Moreover, it may
explain the therapeutic failure of drugs such as pentoxifylline
(Idro et al., 2010), since such drugs may not cross the BBB to
inhibit activated microglia.
Apoptosis of neurons, endothelial cell and astrocytes has been
suggested to play a role in the genesis of symptoms and signs
of experimental animal CM (Wiese et al., 2006; Lackner et al.,
2007). Evidence also suggest that P. falciparum induces apoptosis
of neurons, brain endothelial cell and astrocytes and might play
a role in the pathogenesis of human CM pathology (Pino et al.,
2003; Toure et al., 2008; Idro et al., 2010; N’dilimabaka et al.,
2014). However, the cause and exact mechanisms underlying
induction of apoptosis in these cells is not fully understood.
Elevated brain ammoniamight play a role. In one study, exposure
of C6 glioma cells to 5 or 10mM ammonia for 96 h induced
apoptosis in 50% of the cells, via activation of Protein kinase
C (PKC) and nuclear transcription factor kappa B (NFκB)
pathways (Buzanska et al., 2000). In another study, ammonia
was shown to induce apoptosis of rat hippocampal neurons
via calcineurin-mediated BAD Ser155 dephosphorylation (Yang
et al., 2004). Ammonia was also reported to induce apoptosis in
primary cortical neurons, possibly via reduced phosphorylation
and activation of protein kinase B (PKB or Akt), a key component
in the activation of cellular pro-survival pathways (Klejman et al.,
2005). Over activation of NMDA receptors which can be caused
by elevated ammonia, has also been shown to induce cleavage and
activation of pro-apoptotic caspases (Tenneti et al., 1998).
Interestingly, similar mechanisms seem to mediate the
apoptosis in experimental animal CM and P. falciparum in vitro
models. Activation of pro-apototic caspase 3, for example, was
found to play a key role in neuronal and astrocytic apoptosis in
experimental murine CM (Pino et al., 2003; Potter et al., 2006;
Lackner et al., 2007). Recently also, reduced activation of Akt
and decreased inhibition of the glycogen kinase synthase beta
(GSK3β) was demonstrated in the brains of mice infected with
Plasmodium berghei ANKA (Dai et al., 2012). Our postulated
parasite-driven elevated brain ammonia might thus activate pro-
apoptotic pathways and impair of pro-survival pathways, leading
to apoptosis of neurons, astrocytes, and endothelial cells, thereby
contributing to acute and long-term neuropathology.
Elevated brain ammonia can lead to long-term neurocognitive
sequlae observed among CM survivors via various
pathomechanisms. First, the widespread activation of microglia
by elevated ammonia might predispose neurons to oxidative
burst and lysosomal damage (Schluesener et al., 1998). Secondly,
the overactivation of NMDA receptors by increased extracellular
glutamate acting in synergy with high brain quinolinic acid,
IL-1ß, and TNF-α concentration can lead to excitotoxic damage
of NMDA receptor containing neurons and/or “kindling.” Such
a mechanism may be particularly important in the development
of long-term learning impairment and increased susceptibility
to epilepsy later on in life among peadiatric CM survivors, as
indicated by studies in young rats (Stafstrom and Sasaki-Adams,
2003). Thirdly, the derangement of energy metabolism within
the brain as a result of elevated ammonia-mediated Krebs cycle
inhibition can cause brain cellular damage or death, possibly via
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enhanced cerebral proteolysis as proposed by Ott et al. (2005).
Fourth, the ammonia induced astrocyte swelling and ROS
production, α-KDH inhibition and pro-oxidant kynurenines
production may predispose the neurons to enhanced damaging
effects of oxidative stress. Additionally and perhaps most
important is that neurcognitive sequlae may develop due to
ammonia induced apoptotic death of brain cells (Buzanska et al.,
2000; Yang et al., 2003, 2004). Any of these mechanisms acting
singly or cooperatively could lead to neuronal damage, death
or persistent disturbed synaptic processes, which may in turn
manifest as long-term neurocognitive impairments, following a
CM episode.
Consideration of parasite-driven brain ammonia elevation as
a central pathogenic factor can therefore account for the genesis
of the various manifestations observed in CM patients. It also
allows for the integration of various patho-mechanisms into a
clear sequence of events during the genesis and progression of
CM. Although there are several ethical and practical challenges
to testing of the hypothesized mechanisms in humans with CM,
a number of approaches are possible. CSF ammonia, glutamine,
aspartate, and alanine levels can be measured in well-defined
groups of CM patients. Post mortem analysis of ammonia
metabolizing enzymes and level of ammonia metabolism related
amino acids like glutamate, glutamine, and aspartate could also
be done in brain tissues obtained from fatal cases of cerebral
malaria. The outcome of clinical interventions that limits either
blood, brain ammonia levels, or prevent ammonia-induced brain
dysfunctions may also provide an indirect additional approach.
Murine models of CM can also provide an alternative
approach to test the current hypothesis and its predictions with
the added advantage of allowing experimental manipulations.
Blood, CSF, and brain ammonia levels can be studied in both
the fatal and resolving mouse models of CM. Similarly, pre-
mortem and post-mortem studies of key enzymes involved in
ammonia metabolism including glutamine synthetase, glutamate
dehydrogenase, and glutaminase can provide data to evaluate this
hypothesis.
Therapeutic Implications
If elevated brain ammonia plays a central role in CM
pathogenesis, then interventions that reduces ammonia
formation or toxicity could potential improve CM treatment
outcome. Protein intake restriction during cerebral malaria and
promotion of anabolism by rapid administration of intravenous
dextrose solution could therefore reduce ammonia formation
and toxicity. Similarly, aggressive control of factors such as
fever and seizures, which enhances ammonia formation, may be
beneficial.
Chemical compounds that act as metabolic “sinks” for
ammonia can also be explored as adjuncts in the management
of CM. These include compounds such as benzoate, sodium
phenylacetate, and calcium phenylbutyrate. These agents are
currently used in the management of various hyperammonemic
disorders. Hypothermia and other interventions aimed at
mitigating ammonia induced brain dysfunction and damage may
also be tested as potential adjunct therapies in the management
of CM. Hypothermia has been found to reduce ICP in patients
with ALF (Jalan et al., 1999, 2004a). It would be therefore
interesting to test the efficacy of mild hypothermia in reducing
CM-induced brain edema and raised ICP. More recently, several
experimental agents including NMDA receptor antagonists,
drugs antagonizing endogenous ammonia-activated ouabain-like
compounds, Na-K-Cl cotransporter-1 (NKCC1) inhibitors, and
L-histidine have shown therapeutic potential in ALF animal
models (Rama Rao et al., 2010c; Jayakumar et al., 2011; Cauli
et al., 2013; Song and Du, 2014). These agents may also represent
novel and potentially relevant experimental adjunctive therapies
in CM.
Conclusion
The similar clinicopathological features of CM and
hyperammonemic encephalopathies as well as the available
evidence suggesting that P. falciparum can produce substantial
amount of ammonia warrants the consideration of parasite-
derived ammonia as a potential key factor in the pathogenesis
of cerebral malaria. Predictable consequences of P. falciparum-
induced elevation of brain ammonia can account for most of
clinicopathology of CM and therefore provide hints of potential
adjunctive therapies. Targeting of the parasite’s ammonia
production and transport via PfAQP blockade could also be a
novel therapeutic strategy.
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